Literature DB >> 26950238

Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection.

Marc Beyer1,2, Zeinab Abdullah3, Jens M Chemnitz4, Daniela Maisel4, Jil Sander1, Clara Lehmann4,5, Yasser Thabet1,6, Prashant V Shinde6, Lisa Schmidleithner1, Maren Köhne1, Jonel Trebicka7, Robert Schierwagen7, Andrea Hofmann1,8, Alexey Popov1, Karl S Lang9, Annette Oxenius10, Thorsten Buch11, Christian Kurts3, Mathias Heikenwalder12,13, Gerd Fätkenheuer4,5, Philipp A Lang6,14, Pia Hartmann4,5,15, Percy A Knolle3,16, Joachim L Schultze1,2.   

Abstract

Persistent viral infections are characterized by the simultaneous presence of chronic inflammation and T cell dysfunction. In prototypic models of chronicity--infection with human immunodeficiency virus (HIV) or lymphocytic choriomeningitis virus (LCMV)--we used transcriptome-based modeling to reveal that CD4(+) T cells were co-exposed not only to multiple inhibitory signals but also to tumor-necrosis factor (TNF). Blockade of TNF during chronic infection with LCMV abrogated the inhibitory gene-expression signature in CD4(+) T cells, including reduced expression of the inhibitory receptor PD-1, and reconstituted virus-specific immunity, which led to control of infection. Preventing signaling via the TNF receptor selectively in T cells sufficed to induce these effects. Targeted immunological interventions to disrupt the TNF-mediated link between chronic inflammation and T cell dysfunction might therefore lead to therapies to overcome persistent viral infection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26950238     DOI: 10.1038/ni.3399

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  50 in total

1.  Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery.

Authors:  Shaobo Han; Ayuna Asoyan; Hannah Rabenstein; Naoko Nakano; Reinhard Obst
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

Review 2.  Crosstalk in NF-κB signaling pathways.

Authors:  Andrea Oeckinghaus; Matthew S Hayden; Sankar Ghosh
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

Review 3.  Regulation of antiviral T cell responses by type I interferons.

Authors:  Josh Crouse; Ulrich Kalinke; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2015-03-20       Impact factor: 53.106

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

6.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

7.  A vital role for interleukin-21 in the control of a chronic viral infection.

Authors:  John S Yi; Ming Du; Allan J Zajac
Journal:  Science       Date:  2009-05-14       Impact factor: 47.728

8.  The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease.

Authors:  E J Cepeda; F M Williams; M L Ishimori; M H Weisman; J D Reveille
Journal:  Ann Rheum Dis       Date:  2007-12-13       Impact factor: 19.103

9.  RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma.

Authors:  Jens M Chemnitz; Daniela Eggle; Julia Driesen; Sabine Classen; James L Riley; Svenja Debey-Pascher; Marc Beyer; Alexey Popov; Thomas Zander; Joachim L Schultze
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

Review 10.  Cytokine determinants of viral tropism.

Authors:  Grant McFadden; Mohamed R Mohamed; Masmudur M Rahman; Eric Bartee
Journal:  Nat Rev Immunol       Date:  2009-08-21       Impact factor: 53.106

View more
  30 in total

Review 1.  CD4+ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.

Authors:  Laura A Vella; Ramin S Herati; E John Wherry
Journal:  Trends Mol Med       Date:  2017-11-12       Impact factor: 11.951

2.  Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation.

Authors:  James W Austin; Clarisa M Buckner; Lela Kardava; Wei Wang; Xiaozhen Zhang; Valerie A Melson; Ryan G Swanson; Andrew J Martins; Julian Q Zhou; Kenneth B Hoehn; J Nicholas Fisk; Yiannis Dimopoulos; Alexander Chassiakos; Sijy O'Dell; Margery G Smelkinson; Catherine A Seamon; Richard W Kwan; Michael C Sneller; Stefania Pittaluga; Nicole A Doria-Rose; Adrian McDermott; Yuxing Li; Tae-Wook Chun; Steven H Kleinstein; John S Tsang; Constantinos Petrovas; Susan Moir
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

3.  Tumor-necrosis factor is a master of T cell exhaustion.

Authors:  Amy E Baxter; Daniel E Kaufmann
Journal:  Nat Immunol       Date:  2016-05       Impact factor: 25.606

Review 4.  Successful and Maladaptive T Cell Aging.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Immunity       Date:  2017-03-21       Impact factor: 31.745

5.  Comparison of silver nanoparticle-induced inflammatory responses between healthy and metabolic syndrome mouse models.

Authors:  Lisa Kobos; Saeed Alqahtani; Li Xia; Vincent Coltellino; Riley Kishman; Daniel McIlrath; Carlos Perez-Torres; Jonathan Shannahan
Journal:  J Toxicol Environ Health A       Date:  2020-04-12

Review 6.  Insights into the biology and therapeutic implications of TNF and regulatory T cells.

Authors:  Benoit L Salomon
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 20.543

7.  Alcohol intake alters immune responses and promotes CNS viral persistence in mice.

Authors:  Jennifer M Loftis; Jonathan Taylor; Hans-Peter Raué; Mark K Slifka; Elaine Huang
Journal:  Behav Brain Res       Date:  2016-06-04       Impact factor: 3.332

Review 8.  CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Authors:  Alexandra M Miggelbrink; Joshua D Jackson; Selena J Lorrey; Ethan S Srinivasan; Jessica Waibl-Polania; Daniel S Wilkinson; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2021-06-14       Impact factor: 12.531

9.  An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.

Authors:  Ruth Flümann; Tim Rehkämper; Pascal Nieper; Hans Christian Reinhardt; Gero Knittel; Pauline Pfeiffer; Alessandra Holzem; Sebastian Klein; Sanil Bhatia; Moritz Kochanek; Ilmars Kisis; Benedikt W Pelzer; Heinz Ahlert; Julia Hauer; Alexandra da Palma Guerreiro; Jeremy A Ryan; Maurice Reimann; Arina Riabinska; Janica Wiederstein; Marcus Krüger; Martina Deckert; Janine Altmüller; Andreas R Klatt; Lukas P Frenzel; Laura Pasqualucci; Wendy Béguelin; Ari M Melnick; Sandrine Sander; Manuel Montesinos-Rongen; Anna Brunn; Philipp Lohneis; Reinhard Büttner; Hamid Kashkar; Arndt Borkhardt; Anthony Letai; Thorsten Persigehl; Martin Peifer; Clemens A Schmitt
Journal:  Blood Cancer Discov       Date:  2021-01

10.  Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment.

Authors:  Shota Aoyama; Ryosuke Nakagawa; Satoshi Nemoto; Patricio Perez-Villarroel; James J Mulé; Adam William Mailloux
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.